Kathryn E Lafond1,2, Rachael M Porter1, Melissa J Whaley3, Zhou Suizan4, Zhang Ran4, Mohammad Abdul Aleem5, Binay Thapa6, Borann Sar7, Viviana Sotomayor Proschle8, Zhibin Peng9, Luzhao Feng10, Daouda Coulibaly11, Edith Nkwembe12, Alfredo Olmedo13, William Ampofo14, Siddhartha Saha15, Mandeep Chadha16, Amalya Mangiri17, Vivi Setiawaty18, Sami Sheikh Ali19, Sandra S Chaves20, Dinagul Otorbaeva21, Onechanh Keosavanh22, Majd Saleh23, Antonia Ho24,25, Burmaa Alexander26, Hicham Oumzil27,28, Kedar Prasad Baral29, Q Sue Huang30, Adedeji A Adebayo31, Idris Al-Abaidani32, Marta von Horoch33, Cheryl Cohen34, Stefano Tempia1,35,36, Vida Mmbaga37, Malinee Chittaganpitch38, Mariana Casal39, Duc Anh Dang40, Paula Couto41, Harish Nair42, Joseph S Bresee1, Sonja J Olsen1, Eduardo Azziz-Baumgartner1, J Pekka Nuorti2,43, Marc-Alain Widdowson44,45. 1. Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. 2. Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland. 3. US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. 4. Influenza Division, US Centers for Disease Control and Prevention, Beijing, China. 5. Program for Emerging Infections, Infectious Diseases Division, icddr,b, Dhaka, Bangladesh. 6. Royal Centre for Disease Control, Thimphu, Bhutan. 7. Centers for Disease Control and Prevention, Phnom Penh, Cambodia. 8. Department of Epidemiology, Ministerio de Salud, Santiago, Chile. 9. Division of Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China. 10. School of Population Medicine & Public Health, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China. 11. Institut National d'Hygiène Publique, Abidjan, Côte d'Ivoire. 12. Institut National de Recherches Biomédicales, Kinshasa, République Démocratique du Congo. 13. Ministerio de Salud, Quito, Ecuador. 14. Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Accra, Ghana. 15. Influenza Division, US Centers for Disease Control and Prevention, New Delhi, India. 16. National Institute of Virology, Pune, India. 17. US Centers for Disease Control and Prevention, Jakarta, Indonesia. 18. National Institute of Health Research and Development, Jakarta, Indonesia. 19. Ministry of Health, Amman, Jordan. 20. Influenza Division, US Centers for Disease Control and Prevention, Nairobi, Kenya. 21. Department of State Sanitary Epidemiological Surveillance, Bishkek, Kyrgyzstan. 22. National Center for Laboratory and Epidemiology, Vientiane, Lao People's Democratic Republic. 23. Epidemiological Surveillance Program, Lebanese Ministry of Public Health, Beirut, Lebanon. 24. MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom. 25. Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi. 26. National Centre for Communicable Disease, Ulaanbaatar, Mongolia. 27. Virology Department, Institut National d'Hygiène, Rabat, Morocco. 28. Faculty of Medicine, Microbiology RPU, Mohammed V University, Rabat, Morocco. 29. Patan Academy of Health Sciences, Lalitpur, Nepal. 30. WHO National Influenza Centre, Institute of Environmental Science and Research, Wellington, New Zealand. 31. Nigeria Centre for Disease Control, Federal Ministry of Health, Abuja, Nigeria. 32. Directorate General of Disease Surveillance and Control, Ministry of Health, Muscat, Oman. 33. Ministerio de Salud Publica y Bienestar Social, Asunción, Paraguay. 34. National Institute for Communicable Diseases, Johannesburg, South Africa. 35. MassGenics, Duluth, Georgia, United States of America. 36. School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. 37. Ministry of Health, Dar es Salaam, Tanzania. 38. National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand. 39. Arizona Department of Health Services, Phoenix, Arizona, United States of America. 40. National Institute of Hygiene and Epidemiology, Hanoi, Vietnam. 41. Pan American Health Organization, Washington, District of Columbia, United States of America. 42. Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom. 43. Finnish Institute for Health and Welfare, Helsinki, Finland. 44. Division of Global Health Protection, US Centers for Disease Control and Prevention, Nairobi, Kenya. 45. Institute of Tropical Medicine, Antwerp, Belgium.
Abstract
BACKGROUND: Influenza illness burden is substantial, particularly among young children, older adults, and those with underlying conditions. Initiatives are underway to develop better global estimates for influenza-associated hospitalizations and deaths. Knowledge gaps remain regarding the role of influenza viruses in severe respiratory disease and hospitalizations among adults, particularly in lower-income settings. METHODS AND FINDINGS: We aggregated published data from a systematic review and unpublished data from surveillance platforms to generate global meta-analytic estimates for the proportion of acute respiratory hospitalizations associated with influenza viruses among adults. We searched 9 online databases (Medline, Embase, CINAHL, Cochrane Library, Scopus, Global Health, LILACS, WHOLIS, and CNKI; 1 January 1996-31 December 2016) to identify observational studies of influenza-associated hospitalizations in adults, and assessed eligible papers for bias using a simplified Newcastle-Ottawa scale for observational data. We applied meta-analytic proportions to global estimates of lower respiratory infections (LRIs) and hospitalizations from the Global Burden of Disease study in adults ≥20 years and by age groups (20-64 years and ≥65 years) to obtain the number of influenza-associated LRI episodes and hospitalizations for 2016. Data from 63 sources showed that influenza was associated with 14.1% (95% CI 12.1%-16.5%) of acute respiratory hospitalizations among all adults, with no significant differences by age group. The 63 data sources represent published observational studies (n = 28) and unpublished surveillance data (n = 35), from all World Health Organization regions (Africa, n = 8; Americas, n = 11; Eastern Mediterranean, n = 7; Europe, n = 8; Southeast Asia, n = 11; Western Pacific, n = 18). Data quality for published data sources was predominantly moderate or high (75%, n = 56/75). We estimate 32,126,000 (95% CI 20,484,000-46,129,000) influenza-associated LRI episodes and 5,678,000 (95% CI 3,205,000-9,432,000) LRI hospitalizations occur each year among adults. While adults <65 years contribute most influenza-associated LRI hospitalizations and episodes (3,464,000 [95% CI 1,885,000-5,978,000] LRI hospitalizations and 31,087,000 [95% CI 19,987,000-44,444,000] LRI episodes), hospitalization rates were highest in those ≥65 years (437/100,000 person-years [95% CI 265-612/100,000 person-years]). For this analysis, published articles were limited in their inclusion of stratified testing data by year and age group. Lack of information regarding influenza vaccination of the study population was also a limitation across both types of data sources. CONCLUSIONS: In this meta-analysis, we estimated that influenza viruses are associated with over 5 million hospitalizations worldwide per year. Inclusion of both published and unpublished findings allowed for increased power to generate stratified estimates, and improved representation from lower-income countries. Together, the available data demonstrate the importance of influenza viruses as a cause of severe disease and hospitalizations in younger and older adults worldwide.
BACKGROUND: Influenza illness burden is substantial, particularly among young children, older adults, and those with underlying conditions. Initiatives are underway to develop better global estimates for influenza-associated hospitalizations and deaths. Knowledge gaps remain regarding the role of influenza viruses in severe respiratory disease and hospitalizations among adults, particularly in lower-income settings. METHODS AND FINDINGS: We aggregated published data from a systematic review and unpublished data from surveillance platforms to generate global meta-analytic estimates for the proportion of acute respiratory hospitalizations associated with influenza viruses among adults. We searched 9 online databases (Medline, Embase, CINAHL, Cochrane Library, Scopus, Global Health, LILACS, WHOLIS, and CNKI; 1 January 1996-31 December 2016) to identify observational studies of influenza-associated hospitalizations in adults, and assessed eligible papers for bias using a simplified Newcastle-Ottawa scale for observational data. We applied meta-analytic proportions to global estimates of lower respiratory infections (LRIs) and hospitalizations from the Global Burden of Disease study in adults ≥20 years and by age groups (20-64 years and ≥65 years) to obtain the number of influenza-associated LRI episodes and hospitalizations for 2016. Data from 63 sources showed that influenza was associated with 14.1% (95% CI 12.1%-16.5%) of acute respiratory hospitalizations among all adults, with no significant differences by age group. The 63 data sources represent published observational studies (n = 28) and unpublished surveillance data (n = 35), from all World Health Organization regions (Africa, n = 8; Americas, n = 11; Eastern Mediterranean, n = 7; Europe, n = 8; Southeast Asia, n = 11; Western Pacific, n = 18). Data quality for published data sources was predominantly moderate or high (75%, n = 56/75). We estimate 32,126,000 (95% CI 20,484,000-46,129,000) influenza-associated LRI episodes and 5,678,000 (95% CI 3,205,000-9,432,000) LRI hospitalizations occur each year among adults. While adults <65 years contribute most influenza-associated LRI hospitalizations and episodes (3,464,000 [95% CI 1,885,000-5,978,000] LRI hospitalizations and 31,087,000 [95% CI 19,987,000-44,444,000] LRI episodes), hospitalization rates were highest in those ≥65 years (437/100,000 person-years [95% CI 265-612/100,000 person-years]). For this analysis, published articles were limited in their inclusion of stratified testing data by year and age group. Lack of information regarding influenza vaccination of the study population was also a limitation across both types of data sources. CONCLUSIONS: In this meta-analysis, we estimated that influenza viruses are associated with over 5 million hospitalizations worldwide per year. Inclusion of both published and unpublished findings allowed for increased power to generate stratified estimates, and improved representation from lower-income countries. Together, the available data demonstrate the importance of influenza viruses as a cause of severe disease and hospitalizations in younger and older adults worldwide.
Authors: Stefan Gravenstein; H Edward Davidson; Monica Taljaard; Jessica Ogarek; Pedro Gozalo; Lisa Han; Vincent Mor Journal: Lancet Respir Med Date: 2017-07-20 Impact factor: 30.700
Authors: Katherine A Poehling; Kathryn M Edwards; Marie R Griffin; Peter G Szilagyi; Mary A Staat; Marika K Iwane; Beverly M Snively; Cynthia K Suerken; Caroline B Hall; Geoffrey A Weinberg; Sandra S Chaves; Yuwei Zhu; Monica M McNeal; Carolyn B Bridges Journal: Pediatrics Date: 2013-01-06 Impact factor: 7.124
Authors: A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee Journal: Lancet Date: 2017-12-14 Impact factor: 79.321
Authors: Allen L Nazareno; David J Muscatello; Robin M Turner; James G Wood; Hannah C Moore; Anthony T Newall Journal: Influenza Other Respir Viruses Date: 2022-06-30 Impact factor: 5.606
Authors: Randall C Gunther; Vanthana Bharathi; Stephen D Miles; Lauryn R Tumey; Clare M Schmedes; Kohei Tatsumi; Meagan D Bridges; David Martinez; Stephanie A Montgomery; Melinda A Beck; Eric Camerer; Nigel Mackman; Silvio Antoniak Journal: Front Immunol Date: 2021-12-01 Impact factor: 7.561
Authors: W John Edmunds; Marc Baguelin; Charlie Diamond; Hui Gong; Fiona Yueqian Sun; Yang Liu; Billy J Quilty; Mark Jit; Juan Yang; Hongjie Yu Journal: BMC Med Date: 2022-02-10 Impact factor: 8.775
Authors: Joan Puig-Barberà; Sonia Tamames-Gómez; Pedro Plans-Rubio; José María Eiros-Bouza Journal: Int J Environ Res Public Health Date: 2022-01-12 Impact factor: 3.390